Meline David W
- SEC CIK
- 0001444612
No open-market purchases or sales filed in the past year.
Current role at each company
- HPQ HP IncDirectoras of Apr 20, 2026
- PACB Pacific Biosciences of California, Inc.Directoras of Jun 20, 2024
- MRNA Moderna, Inc.Chief Financial Officeras of Aug 11, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Meline David W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PACB Pacific Biosciences of California, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 (view filing) | Mar 6 | Same day | Meline David WDirector | PPurchase | +40.0K | $4.40 | +$176.0K | New position40.0K after |
MRNA Moderna, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 (view filing) | Aug 10 | 1 day | Meline David WChief Financial Officer | SSale | −164 | $173.66 | −$28.5K | −5.4%2.86K after | |
| May 11, 2022 (view filing) | May 10 | 1 day | Meline David WChief Financial Officer | SSale | −156 | $133.71 | −$20.9K | −5.7%2.58K after | |
| Feb 11, 2022 (view filing) | Feb 10 | 1 day | Meline David WChief Financial Officer | SSale | −619 | $158.89 | −$98.4K | −20.6%2.39K after |